Oxford Sciences Innovation is a science business builder. We build world-changing businesses, bringing Oxford science to the world faster.


Since 2015, we have worked with over 200 of Oxford’s leading academics to build a portfolio of more than 100 companies, worth over $2 billion, all based on Oxford science, created +1,500 new jobs and added +55,000 square-feet of laboratory and startup space; building on Oxford’s renowned research legacy to create a leading science ecosystem. A place where scientific breakthroughs become world-changing businesses.

Our portfolio of companies spans four sectors, Life Sciences, Deep Tech, Health Tech and Software & AI, tackling challenges like the diagnosis and treatment of devastating rare diseases and cancer, sustainability, nuclear fusion, quantum computing and cyber-security.

Vaccitech, co-inventor of the Oxford Vaccine, Base Genomics, creator of early-stage cancer detection technology, and First Light Fusion, making clean, virtually limitless energy a reality, are just three examples of the impact our companies are making.

We start with the world’s best science

The University of Oxford is home to some of the world’s most creative and innovative scientific thinkers and leaders, ranked #1 in the world for scientific research. Our unique partnership grants us unrivalled access to Oxford’s academics, research and IP within the Medical Sciences and Mathematics, Physical and Life Sciences Divisions. We identify; cutting-edge research, scientific breakthroughs and advances in technology capable of changing the world and turn these game-changing ideas into credible businesses.

We build world-changing businesses

We are expert business builders and bring unique resources to inspire, accelerate and maximise impact. We do this by matching Oxford science with world-class talent, business building know-how, industry-leading experts, a global network and capital.

We are a company and that makes us unique. We can be disruptive; we can be patient; we can experiment; we can supercharge.


Stay up to date

Get the latest on cutting-edge developments in our portfolio, straight to your inbox.